Archive for the ‘Trials’ Category
Stephan Moll, MD writes… A clinical research study is being conducted in the U.S. for the treatment of chronic deep vein thrombosis (DVT) with post-thrombotic syndrome (PTS) and is open for enrollment. It is referred to as ACCESS-PTS. Read the rest of this entry »
Stephan Moll, MD writes…
An important study (called AMPLIFY trial) was published today in the New England Journal of Medicine [ref 1]. In a large study of patients with acute DVT or PE, Eliquis (apixaban) was as effective as warfarin and caused less major bleeding. Read the rest of this entry »
It is known that the risk for blood clots in the leg (DVT) and lung (PE) is partly inherited. Some genes that increase the risk for DVT and PE are known (e.g. factor V Leiden, the factor II 20210 mutation, protein, protein C, S and antithrombin mutations). However, it is suspected that many other and, as yet, unidentified genes also increase the risk for DVT and PE. One of the ways to discover such clotting genes is by studying families.
A study is presently ongoing at the Mayo Clinic in Rochester, MN, that is investigating what genes put people at risk for clots (DVT and PE). Read the rest of this entry »
If you or somebody you know has been diagnosed in the last 14 days with a new DVT of the leg (thigh or pelvic veins), I would encourage you to consider participation in the ATTRACT trial – a solid, clinically useful study (NIH funded) that investigates how to minimize the long-term complications after a blood clot – chronic leg pain and swelling (called the post-thrombotic syndrome).
The study investigates Read the rest of this entry »